NADMED attends Slush 2022

NADMED attends Slush 2022

NADMED is attending this year’s Slush event 17.-18.11. with the University of Helsinki. You can find NADMED with Health Incubator Helsinki (area 18, stand E.10). NADMED is looking forward to exciting two days of meetings, mingling, networking and the famous...
Setting the standard in NAD profiling

Setting the standard in NAD profiling

NADMED was chosen among the best clinical laboratory services in Europe. The selection was made by one of the Europe’s leading health tech magazines Life Science Review. The magazine interviewed NADMED’s COO Jana Buzkova, who tells about the new standards...
Voima Ventures to back NADMED

Voima Ventures to back NADMED

The easy and reliable method that measures all NAD metabolites has also convinced financiers. NADMED recently completed its first financing round of half a million euros, led by deep tech fund Voima Ventures. Other investors include individuals and members of the...
New opportunities at NLSDays

New opportunities at NLSDays

NADMED raised a lot of interest among the VC investors at Nordic Life Science days 2022 in Malm√∂, Sweden. Investors were particularly enthusiastic about NADMED’s first three quarters’ business development. NADMED is currently growing rapidly selling...
NADMED attends ARDD 2022

NADMED attends ARDD 2022

Leaders in the aging and longevity field are gathered in the 9th Aging Research and Drug Discovery meeting in Copenhagen from 29th of August. NADMED is joining the event where the experts will describe the latest progress in the molecular, cellular and organismal...